04/04/2025 3:16 PM | BioXcel Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
04/03/2025 3:32 PM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/03/2025 3:30 PM | BioXcel Therapeutics (Filer)
| Form 424B5 | |
04/01/2025 5:08 PM | BioXcel Therapeutics (Issuer) O'Neill Vincent (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/01/2025 5:02 PM | BioXcel Therapeutics (Issuer) MACK DAVID J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/01/2025 5:02 PM | BioXcel Therapeutics (Issuer) Yocca Frank (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/01/2025 5:04 PM | BioXcel Therapeutics (Issuer) Rodriguez Javier (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/01/2025 5:06 PM | BioXcel Therapeutics (Issuer) Wiley Matthew T. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/01/2025 5:07 PM | BioXcel Therapeutics (Issuer) Steinhart Richard I (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/01/2025 5:08 PM | BioXcel Therapeutics (Issuer) Mehta Vimal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/21/2025 4:00 PM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for BTAI and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for BioXcel Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
03/21/2025 6:00 AM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/17/2025 5:35 PM | BioXcel Therapeutics (Issuer) Mehta Vimal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/17/2025 5:36 PM | BioXcel Therapeutics (Issuer) Yocca Frank (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/17/2025 5:37 PM | BioXcel Therapeutics (Issuer) Rodriguez Javier (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/17/2025 5:38 PM | BioXcel Therapeutics (Issuer) Steinhart Richard I (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2025 8:21 PM | BioXcel Therapeutics (Issuer) MACK DAVID J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2025 7:51 AM | BioXcel Therapeutics (Filer)
| Form 424B5 | |
03/03/2025 7:42 AM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2025 4:27 PM | ARMISTICE CAPITAL, LLC (Filed by) BioXcel Therapeutics (Subject)
| Form SCHEDULE 13G | |
02/06/2025 7:44 AM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/04/2025 4:28 PM | BioXcel Therapeutics (Issuer) MACK DAVID J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/29/2025 3:15 PM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/20/2025 11:15 PM | BioXcel Therapeutics (Filer)
| Form EFFECT | |
01/16/2025 7:00 AM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/16/2025 7:03 AM | BioXcel Therapeutics (Issuer) Patni Rajiv (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/16/2025 7:04 AM | BioXcel Therapeutics (Issuer) Patni Rajiv (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/10/2025 7:00 PM | BioXcel Therapeutics (Issuer) Steinhart Richard I (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/10/2025 7:01 PM | BioXcel Therapeutics (Issuer) Yocca Frank (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/10/2025 7:03 PM | BioXcel Therapeutics (Issuer) Mehta Vimal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/10/2025 3:45 PM | BioXcel Therapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
01/08/2025 6:45 AM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/30/2024 3:15 PM | BioXcel Therapeutics (Filer)
| Form DEF 14A | |
12/18/2024 7:19 PM | BioXcel Therapeutics (Subject) Oaktree Capital Group Holdings GP, LLC (Filed by)
| Form SCHEDULE 13G | |
12/18/2024 4:16 PM | BioXcel Therapeutics (Filer)
| Form PRE 14A | |
12/18/2024 4:20 PM | BioXcel Therapeutics (Subject) Qatar Investment Authority (Filed by)
| Form SCHEDULE 13G | |
12/17/2024 5:10 PM | BioXcel Therapeutics (Issuer) O'Neill Vincent (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/17/2024 5:03 PM | BioXcel Therapeutics (Issuer) Yocca Frank (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/17/2024 5:04 PM | BioXcel Therapeutics (Issuer) Rodriguez Javier (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/17/2024 5:06 PM | BioXcel Therapeutics (Issuer) Steinhart Richard I (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/17/2024 5:08 PM | BioXcel Therapeutics (Issuer) Mehta Vimal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
The next market Nvidia is positioned to dominate … (Ad) Robots — built by Nvidia.
Forbes says this could be " a $24 trillion opportunity for investors."
Huang said, "The ChatGPT moment for robotics is right around the corner."
In fact, I believe these robots could impact 65 million Americans lives — this year.
And one stock — currently priced around $7 — could be the biggest winner. To see a live demonstration with one of these robots, simply click here. |
12/16/2024 3:21 PM | BioXcel Therapeutics (Subject) O'Neill Vincent (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/16/2024 2:33 PM | BioXcel Therapeutics (Subject) Steinhart Richard I (Reporting)
| Form 144/A | |
12/16/2024 2:23 PM | BioXcel Therapeutics (Subject) Yocca Frank (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/16/2024 2:00 PM | BioXcel Therapeutics (Subject) Steinhart Richard I (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/16/2024 1:10 PM | BioXcel Therapeutics (Subject) Mehta Vimal (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/25/2024 3:05 PM | BioXcel Therapeutics (Issuer) MACK DAVID J. (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
11/25/2024 3:06 PM | BioXcel Therapeutics (Issuer) MACK DAVID J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/25/2024 5:00 AM | BioXcel Therapeutics (Filer)
| Form 424B5 | |
11/21/2024 3:43 PM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/21/2024 3:46 PM | BioXcel Therapeutics (Filer)
| Form 424B5 | |
11/14/2024 8:10 AM | BioXcel Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/14/2024 6:00 AM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/09/2024 3:08 PM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/03/2024 8:53 PM | BioXcel Therapeutics (Issuer) O'Neill Vincent (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2024 8:54 PM | BioXcel Therapeutics (Issuer) Steinhart Richard I (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2024 8:54 PM | BioXcel Therapeutics (Issuer) Yocca Frank (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2024 8:55 PM | BioXcel Therapeutics (Issuer) Rodriguez Javier (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2024 8:55 PM | BioXcel Therapeutics (Issuer) Wiley Matthew T. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2024 3:33 PM | BioXcel Therapeutics (Subject) Wiley Matthew T. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/03/2024 3:40 PM | BioXcel Therapeutics (Subject) Rodriguez Javier (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/03/2024 3:17 PM | BioXcel Therapeutics (Subject) Yocca Frank (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/19/2024 6:00 AM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/17/2024 6:17 PM | BioXcel Therapeutics (Issuer) Wiley Matthew T. (Reporting)
| Form 4/A | |
09/17/2024 6:18 PM | BioXcel Therapeutics (Issuer) Wiley Matthew T. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/17/2024 6:19 PM | BioXcel Therapeutics (Issuer) O'Neill Vincent (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/17/2024 6:20 PM | BioXcel Therapeutics (Issuer) Rodriguez Javier (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/17/2024 6:21 PM | BioXcel Therapeutics (Issuer) Steinhart Richard I (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/17/2024 6:21 PM | BioXcel Therapeutics (Issuer) Mehta Vimal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/17/2024 6:23 PM | BioXcel Therapeutics (Issuer) Yocca Frank (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/16/2024 4:42 PM | BioXcel Therapeutics (Subject) Yocca Frank (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024 4:26 PM | BioXcel Therapeutics (Subject) Wiley Matthew T. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024 4:16 PM | BioXcel Therapeutics (Subject) Rodriguez Javier (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024 2:48 PM | BioXcel Therapeutics (Subject) O'Neill Vincent (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024 1:58 PM | BioXcel Therapeutics (Subject) Steinhart Richard I (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024 12:23 PM | BioXcel Therapeutics (Subject) Mehta Vimal (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/10/2024 9:47 AM | BioXcel Therapeutics (Subject) FMR LLC (Filed by)
| Form SC 13G/A | |
09/09/2024 3:15 PM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/05/2024 6:16 AM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/06/2024 6:05 AM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/17/2024 3:41 PM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/16/2024 6:00 AM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/25/2024 6:05 AM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/18/2024 8:22 PM | BioXcel Therapeutics (Issuer) O'Neill Vincent (Reporting)
| Form 4/A | |
06/18/2024 8:24 PM | BioXcel Therapeutics (Issuer) Mehta Vimal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/18/2024 8:25 PM | BioXcel Therapeutics (Issuer) O'Neill Vincent (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/18/2024 8:25 PM | BioXcel Therapeutics (Issuer) Rodriguez Javier (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/18/2024 8:26 PM | BioXcel Therapeutics (Issuer) Steinhart Richard I (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/18/2024 8:26 PM | BioXcel Therapeutics (Issuer) Wiley Matthew T. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/18/2024 8:27 PM | BioXcel Therapeutics (Issuer) Yocca Frank (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2024 2:13 PM | BioXcel Therapeutics (Subject) Rodriguez Javier (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Here’s How to Claim Your Stake in Elon’s Private Company, xAI (Ad) I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history.
And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI. All the details are waiting for you now — but you need to act before the May 1st funding window clos |
06/17/2024 1:34 PM | BioXcel Therapeutics (Subject) Wiley Matthew T. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024 1:09 PM | BioXcel Therapeutics (Subject) O'Neill Vincent (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024 12:46 PM | BioXcel Therapeutics (Subject) Yocca Frank (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024 12:04 PM | BioXcel Therapeutics (Subject) Mehta Vimal (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024 12:21 PM | BioXcel Therapeutics (Subject) Steinhart Richard I (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/11/2024 6:00 PM | BioXcel Therapeutics (Issuer) Bray June (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/11/2024 6:00 PM | BioXcel Therapeutics (Issuer) MILLER MICHAEL PATRICK (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/11/2024 6:01 PM | BioXcel Therapeutics (Issuer) MUELLER PETER (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/11/2024 6:01 PM | BioXcel Therapeutics (Issuer) Laumas Sandeep (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |